ImmunityBio is conducting trials of Anktiva in various cancers, including NSCLC and ovarian cancer. Click here to read an analysis of IBRX stock now.

A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...

Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...

Travis Cleve Pierce, 47, Asheboro has been identified as a suspect in the case. He is believed to be an associate of the victim and is wanted on various assault charges related to the incident.

The Department of Veterans Affairs announced earlier this month it’s funding research into psychedelic therapy for veterans with PTSD.

Stay updated on the latest advancements in bladder cancer treatment and the financial decisions of a leading company in the ...

An Alliance man has been charged with two counts of aggravated arson, accused of causing a fire that forced 18 residents from ...

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on MoonLake Immunotherapeutics (MLTX – Research Report), ...

Syntara hopes to emulate the success of Ojjaara, a $2.6 billion home-grown myelofibrosis therapy approved in the US.

Lt. Robert Milam of Kennesaw State Police suffered burns rescuing his family from a fire, losing their home and belongings. A ...

Avita Medical's approved spray-on skin burns treatment Recell has the runs on the board. Now it just has to follow through.

A 40-foot boat in Seattle's Elliott Bay went up in flames Sunday, leading another vessel to rescue the distressed boater, according to the U.S. Coast Guard.